December 06, 2024

Joint research in key technologies: NMI and KIT sign cooperation agreement

Joint research in key technologies: NMI and KIT sign cooperation agreement

The NMI Natural and Medical Sciences Institute and the Karlsruhe Institute of Technology (KIT) have signed a groundbreaking cooperation agreement. This partnership combines the expertise of both institutions in the fields of production and characterization of materials for biological systems and energy storage as well as the application of statistical methods in medicine.

The collaboration will focus on several future-oriented fields of research, such as joint research on different forms of analytics, 3D bioprinting, environmentally friendly energy storage, measures against respiratory infections and AI-supported diagnosis of proteins. The NMI and KIT have already successfully carried out joint research projects in the past. This demonstrates their long-standing collaboration in the fields of biotechnology, medicine and materials science.

“We are excited about the many synergies that will result from the collaboration with KIT and look forward to jointly developing innovative solutions that will be of great benefit to both industry and society,” explains Prof. Dr. Katja Schenke-Layland, Director of the NMI.

“With the cooperation agreement, KIT and the NMI are intensifying their long-standing and trusting collaboration in the fields of biotechnology, medicine and materials science. The resulting innovations will strengthen the locations Baden-Württemberg and Germany,” says Prof. Dr. Thomas Hirth, Vice President International and Transfer at KIT.

As a research university in the Helmholtz Association, KIT is one of Germany’s leading scientific institutions in the engineering and natural sciences. With its interdisciplinary research and close collaboration with partners from industry, it offers an excellent basis for innovative cooperation. In particular, the clusters of excellence and the Helmholtz Institute Ulm for Electrochemical Energy Storage founded by KIT open up promising prospects for the further development of new technologies in partnership. The aim of the cooperation between the NMI and KIT is to work on significant scientific and technological advances that will benefit both sides.

About the KIT:

The Karlsruhe Institute of Technology is one of the most renowned technical universities in Germany. It combines strong basic research with application-oriented development in engineering and natural sciences. Thanks to its interdisciplinary orientation and close links with industry, KIT is a pioneer in the development of future-oriented technologies.

https://www.kit.edu/index.php

Our latest News

discover more
Study shows how lymph node architecture affects cancer growth

Study shows how lymph node architecture affects cancer growth

A new study maps the organisation of immune and stromal cells in lymph nodes and shows how loss of this organisation affects prognosis in certain lymphomas Summary Researchers from EMBL Heidelberg, Heinrich Heine University Düsseldorf (HHU), and Düsseldorf University Hospital (UKD) have succeeded for the first time in mapping the organisation of immune and stromal […]

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

Meningiomas are the most common brain tumors. Until now, only two methods have generally been considered for treating them: surgery and radiation therapy. A research team in Heidelberg has now developed a potential new approach for effective systemic therapy. Its members from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital (UKHD) tested the effectiveness […]

Development of a method for improved monitoring of the early stages of bone marrow cancer

Development of a method for improved monitoring of the early stages of bone marrow cancer

An international team, including researchers from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, has developed the PANGEA-SMM prognostic tool. This tool makes it possible to determine with greater accuracy than before whether a precancerous condition—known as “smoldering multiple myeloma”—is progressing and thus requires treatment. The free online tool for treatment teams is available […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp